GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optomed PLC (FRA:36U0) » Definitions » ROE % Adjusted to Book Value

Optomed (FRA:36U0) ROE % Adjusted to Book Value : -4.29% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Optomed ROE % Adjusted to Book Value?

Optomed's ROE % for the quarter that ended in Dec. 2024 was -16.37%. Optomed's PB Ratio for the quarter that ended in Dec. 2024 was 3.82. Optomed's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -4.29%.


Optomed ROE % Adjusted to Book Value Historical Data

The historical data trend for Optomed's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optomed ROE % Adjusted to Book Value Chart

Optomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -10.20 -7.02 -6.48

Optomed Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.36 -6.09 -7.81 -7.02 -4.29

Competitive Comparison of Optomed's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Optomed's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optomed's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Optomed's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Optomed's ROE % Adjusted to Book Value falls into.


;
;

Optomed ROE % Adjusted to Book Value Calculation

Optomed's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-24.77% / 3.82
=-6.48%

Optomed's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-16.37% / 3.82
=-4.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optomed ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Optomed's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Optomed Business Description

Traded in Other Exchanges
Address
Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.

Optomed Headlines

No Headlines